Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients. (2015). Bangladesh Journal of Pharmacology, 10(3), 489-493. https://doi.org/10.3329/bjp.v10i3.23079